Immunological assay using a solid-state pore with a low limit of detection

Hiroyasu Takei1, Tomoko Nakada2, Lat Wai Leong2

  • 1Aipore Inc., 26-1 Sakuragaokacho, Shibuya, Tokyo, 150-8512, Japan.

Scientific Reports
|July 19, 2024
PubMed

Insights

This study presents a novel method combining immunoreactions and solid-state pores for highly sensitive detection of tumor markers. This breakthrough enables rapid, quantitative point-of-care testing with a significantly lower detection limit.

Area of Science:

  • Biotechnology
  • Nanotechnology
  • Immunology

Background:

  • Immune reactions are crucial for disease detection, relying on antigen-antibody recognition.
  • Solid-state pores offer single-molecule detection by varying pore diameter.
  • Combining these technologies promises sensitive and specific disease testing.

Purpose of the Study:

  • To develop a quantitative analysis method using solid-state pores for disease detection.
  • To achieve a low limit of detection for tumor markers via hybrid technology.
  • To create rapid, sensitive, and specific immunoassay tests.

Main Methods:

  • Utilized a hybrid approach combining immunoreactions with solid-state pore technology.
  • Employed prostate-specific antigen (PSA) and anti-PSA antibody-modified beads.
  • Demonstrated quantitative analysis of bead mixtures and PSA detection.

Main Results:

  • Achieved quantitative analysis of bead mixtures with an error rate up to 4.7%.
  • Reached a detection limit of 24.9 fM for prostate-specific antigen (PSA) in 30 minutes.
  • Demonstrated a lower limit of detection and higher throughput compared to existing immunoassays.

Conclusions:

  • The hybrid solid-state pore and immunoreaction method enables sensitive tumor marker detection.
  • This technology facilitates the development of rapid, easy-to-use point-of-care tests.
  • The method offers improved sensitivity and throughput for immunoassay applications.